Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings per share (EPS) is N/A as of the fiscal period ended Wednesday, December 31, 2025.
Reported quarterly EPS; no daily interpolation. Q2 FY2025 (2025-06-30): -0.65.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 2 comparable quarters.
EARNINGS PER SHARE (EPS)
N/A
EARNINGS PER SHARE (EPS) AVG TTM
-0.34
EARNINGS PER SHARE (EPS) AVG 3Y
-0.07
EARNINGS PER SHARE (EPS) AVG 5Y
0.03
EARNINGS PER SHARE (EPS) AVG 10Y
N/A
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
YD Bio Limited Ordinary Shares
Market Cap
$420.03M
Earnings Per Share (EPS)
N/A
TTM Avg
-0.34
3Y Avg
-0.07
5Y Avg
0.03
Market Cap
$419.58M
Earnings Per Share (EPS)
-2.27
TTM Avg
-2.08
3Y Avg
-0.07
5Y Avg
-5.01
Market Cap
$420.49M
Earnings Per Share (EPS)
-0.75
TTM Avg
-2.34
3Y Avg
-2.48
5Y Avg
-2.46
Market Cap
$417.78M
Earnings Per Share (EPS)
-0.84
TTM Avg
-3.40
3Y Avg
-3.01
5Y Avg
-2.22
Market Cap
$422.04M
Earnings Per Share (EPS)
-2.18
TTM Avg
-0.83
3Y Avg
-0.77
5Y Avg
-0.64
Market Cap
$423.28M
Earnings Per Share (EPS)
-1.33
TTM Avg
-17.45
3Y Avg
-17.77
5Y Avg
-15.77
Market Cap
$425.33M
Earnings Per Share (EPS)
-4.57
TTM Avg
-3.99
3Y Avg
-6.52
5Y Avg
-18.52
Market Cap
$412.91M
Earnings Per Share (EPS)
-5.18
TTM Avg
-2.77
3Y Avg
-1.90
5Y Avg
-1.90
Market Cap
$428.08M
Earnings Per Share (EPS)
-1.98
TTM Avg
-3.65
3Y Avg
-4.15
5Y Avg
-2.79
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| YD Bio Limited Ordinary Shares (YDES) | $420.03M | N/A | -0.34 | -0.07 | 0.03 |
| Senseonics Holdings, Inc. (SENS)vs › | $419.58M | -2.27 | -2.08 | -0.07 | -5.01 |
| Editas Medicine, Inc. (EDIT)vs › | $420.49M | -0.75 | -2.34 | -2.48 | -2.46 |
| Prothena Corporation plc (PRTA)vs › | $417.78M | -0.84 | -3.40 | -3.01 | -2.22 |
| ARS Pharmaceuticals, Inc. (SPRY)vs › | $422.04M | -2.18 | -0.83 | -0.77 | -0.64 |
| Tilray Brands, Inc. (TLRY)vs › | $423.28M | -1.33 | -17.45 | -17.77 | -15.77 |
| Tectonic Therapeutic, Inc. (TECX)vs › | $425.33M | -4.57 | -3.99 | -6.52 | -18.52 |
| MapLight Therapeutics, Inc. (MPLT)vs › | $412.91M | -5.18 | -2.77 | -1.90 | -1.90 |
| NeoGenomics, Inc. (NEO)vs › | $428.08M | -1.98 | -3.65 | -4.15 | -2.79 |
| Strata Critical Medical, Inc. (SRTA)vs › | $410.03M | 0.50 | 0.08 | -0.25 | -0.31 |
Trailing EPS (TTM)
N/A
Forward EPS (Est.)
N/A
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -0.12 |
| 2024-12-31 | -0.56 |
| 2023-12-31 | 0.00 |
| 2022-12-31 | 0.41 |
| 2021-12-31 | 0.59 |
| 2020-12-31 | -0.17 |
